Business
BioSpectrum Asia
New partnership in Norway to strengthen pandemic preparedness
The Coalition for Epidemic Preparedness Innovations (CEPI) and the Norwegian Institute of Public Health (NIPH) have bolstered the long-standing relationship between the two organisations by signing a Memorandum of Understanding (MoU) during a recent meeting between NIPH’s Director General Guri Rørtveit and CEPI’s CEO Richard Hatchett.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Abbott introduces TactiFlex sensor enabled ablation catheter in India
Abbott, the global healthcare company, has announced the launch of the TactiFlex Sensor Enabled Ablation Catheter, the world's first ablation catheter with a flexible tip and contact force technology.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Cariflex opens world's largest polyisoprene latex plant in Singapore
Cariflex, the global market leader in polyisoprene rubber latex for medical-end markets and wholly owned subsidiary of DL Chemical, has officially inaugurated its new polyisoprene latex plant at Jurong Island, Singapore.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Curaleaf International launches range of medical cannabis products in Australia
American firm Curaleaf International, part of Curaleaf Holdings, Inc., has announced the launch of Curaleaf-branded products in Australia.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
PAHO to fortify the Caribbean's fight against AMR
Health leaders, development partners and regional stakeholders recently gathered to launch two synergistic, landmark, regional projects under the United Kingdom (UK) Government’s Fleming Fund and jointly implemented by the Caribbean Public Health Agency (CARPHA), the Pan American Health Organization (PAHO), and the UK Health Security Agency (UKHSA).
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Sonitus Medical grants BHM commercialisation rights outside of China
Sonitus Medical has entered into a strategic cooperation with BHM, a European manufacturer of bone conduction hearing devices.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Dileep Mangsuli becomes Chairman of CTSI, South Asia
Cancer Treatment Services International (CTSI) has announced the appointment of Dileep Mangsuli as Chairman.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Mark Butler steps in as Minister for Disability in Australia
Mark Butler has been appointed as Minister for Health and Ageing, and the Minister for Disability and the National Disability Insurance Scheme, following his swearing-in on May 13, 2025 as a result of Anthony Albanese's Labor government being re-elected at the 2025 Australian federal election.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Terumo takes over Wuxi Biologics' drug product plant in Germany for EUR 150 M
China-based WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organisation (CRDMO), has entered into an agreement with Terumo Corporation that Terumo will take over WuXi Biologics’ drug product (DP) plant in Leverkusen, Germany for EUR 150 million.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Qiagen enhances clinical genomics portfolio with acquisition of Genoox AI-powered software
Netherlands-headquartered Qiagen has signed a definitive agreement to acquire Israel-based Genoox, a provider of artificial intelligence (AI)-powered software that enables clinical labs to scale and accelerate the processing of complex genetic tests.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Maldives and Malaysia exchange MoUs in healthcare and other sectors
An exchange of Memoranda of Understanding (MoUs), and Exchanges of Notes (EoNs) recently took place between the Government of the Republic of Maldives and the Malaysian government.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
“We are developing customised solutions aligned with India’s regulatory and market needs”
US-headquartered Agilent Technologies International has opened its first-ever India Solution Center at its LEED Platinum-certified office in Manesar, Haryana.
2 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Minghui Pharma announces oncology agreement worth $185 M with Qilu Pharma in Greater China
Minghui Pharmaceutical, a latestage clinical biopharmaceutical company, has announced an exclusive licensing and collaboration agreement with Qilu Pharmaceutical for the development, manufacturing, and commercialisation of its B7-H3 ADC (MHB088C) in Greater China (including Mainland China, Hong Kong, Macau, and Taiwan).
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Genezen and Optieum Biotechnologies focus on CAR-T therapy for glioblastoma
Genezen, a US-based viral vector Contract Development and Manufacturing Organisation (CDMO), and Japanese startup Optieum Biotechnologies, Inc., have announced a partnership for cGMP manufacturing of the lentiviral vector (LVV) construct used in the production of OPTF01, a novel CAR-T therapy for glioblastoma treatment.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
New Zealand offers test to help more women beat ovarian cancer
New Zealand’s University of Auckland researchers are working on developing a new test that could help women access a revolutionary treatment for ovarian cancer.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
MUHS to pioneer Emotion-AI in Indian healthcare sector
In a landmark step toward advancing holistic healthcare, the academic wing of the Maharashtra University of Health Sciences (MUHS) in India has officially partnered with Nihilent to explore clinical applications of Emoscape, the company’s innovative AI-based emotion detection platform.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Hong Kong pioneers novel, needle-free, live-attenuated influenza vaccines
A research team led by the School of Public Health in the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with the Centre for Immunology & Infection (C2i), has achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV).
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
US FDA approves first and only at-home selfcollection device for cervical cancer screening
Teal Health, a women's health company on a mission to eliminate cervical cancer, has announced the US Food and Drug Administration's (FDA) approval of the Teal Wand, the first and only at-home vaginal sample self-collection device for cervical cancer screening in the United States (US).
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
"APAC now leads global clinical development of multi-specific antibodies, accounting for over 40% of trials"
According to market projections, the biologics sector is expected to grow from $451 billion in 2024 to $938 billion by 2034, reflecting a CAGR of 7.6 per cent. While biologics, including vaccines, gene therapies, and monoclonal antibodies, offer targeted, effective treatments for cancer, autoimmune disorders, and rare conditions, these can be complex and costly to produce.
4 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Olympus appoints Bob White as new CEO
Japan-based medtech company Olympus Corporation has announced the appointment of a Chief Executive Officer (CEO) aimed at accelerating its ongoing transformation efforts in the medtech space.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Nuclera establishes distribution network across APAC and Middle East
Nuclera, a UK-based biotechnology company accelerating protein expression and optimisation through its benchtop eProtein Discovery System, has established a distribution network across Asia Pacific (APAC) and the Middle East.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
New imaging technique in Japan to personalise heart disease treatment
Researchers from the University of Tokyo, Japan have found a way to observe clotting activity in blood as it happens, without needing invasive procedures.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Nandakumar Kalathil steps in as Country General Manager for Agilent India
Agilent has announced the appointment of Nandakumar (Nanda) Kalathil as the Country General Manager (CGM) for Agilent India.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Johnson & Johnson Medtech partners with Qure.ai to boost early detection of lung cancer in India
Johnson & Johnson MedTech, a global leader in surgical technologies and solutions, has onboarded Indian startup Qure. ai, a global leader in artificial intelligence (AI) for healthcare, as a strategic partner to enhance early detection of lung cancer in India.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Ensuring Compliance with Surprise Inspections
On May 6, the US Food and Drug Administration (US FDA) announced its intent to expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended for American consumers and patients.
2 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Apollomics, LaunXP ink $50 M deal for NSCLC treatment in Asia
US-based Apollomics Inc., and Taiwan-based LaunXP International Co., an affiliate of LaunXP Biomedical Co., have entered into an agreement for the development and commercialisation in Asia (excluding mainland China, Hong Kong and Macau) of vebreltinib, Apollomics' proprietary c-Met inhibitor, in combination with an EGFR inhibitor (EGFRI) for the treatment of non-small cell lung cancer (NSCLC).
1 min |
BioSpectrum Asia May 2025
BioSpectrum Asia
GSK joins hands with Korea's ABL Bio for treatment of neurodegenerative diseases
South Korea-based startup ABL Bio Inc. has announced a worldwide licensing agreement enabling GlaxoSmith-Kline Pharmaceuticals (GSK) to develop novel medicines for neurodegenerative diseases by utilising ABL Bio's blood-brain barrier (BBB) shuttle platform, Grabody-B.
1 min |
BioSpectrum Asia May 2025
BioSpectrum Asia
"The biosimilar developers are eagerly awaiting revised CDSCO regulations that might lead to simplification of the development pathway for biosimilars"
In an interaction with BioSpectrum, I Dr Dr Jitendra Kumar, Managing Director, Biotechnology Industry Research Assistance Council (BIRAC), India reflects on the evolution of India's biosimilars sector and shares his insights on the country's growing role in the global biosimilars landscape over the next decade.
4 min |
BioSpectrum Asia May 2025
BioSpectrum Asia
Rise of Chinese companies in global medtech sector
The global medical technology (medtech) sector is undergoing a profound transformation, driven significantly by the rapid and strategic ascent of Chinese companies. The long-held narrative of China solely as a manufacturer of low-cost goods is dangerously outdated. Today, Chinese medtech firms are not merely competing on the global stage; they are increasingly setting the pace in innovation, enhancing product quality, and expanding their international reach. This shift necessitates a strategic reassessment by established players and presents both significant opportunities and complex challenges for the entire healthcare ecosystem. This article dissects the key drivers behind China's medtech surge, analyses their global expansion strategies, evaluates their competitive positioning, and provides an outlook on the future landscape.
4 min |
BioSpectrum Asia May 2025
BioSpectrum Asia
Medical Device Classification and FDA Approval: What Startups Need to Know
For many innovators, the United States represents a key market, being the world's largest for medical devices. However, entering the US market requires navigating the US Food and Drug Administration's (FDA) stringent regulatory landscape, where accurate device classification is crucial. To assist innovators, the Regulatory Information and Facilitation Center (RIFC) at Venture Center, Pune has released a whitepaper early this year that offers practical insights, featuring examples of devices developed by Venture Center-supported startups to illustrate how medical devices are categorised based on risk.
3 min |